CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates [Yahoo! Finance]
CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates
CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates
Is CG Oncology (CGON) Among the Best IPO Stocks to Buy in 2025? [Yahoo! Finance]